New influenza target
Nature Biotechnology
May 31, 2010
A novel target for killing the influenza A virus is presented in Nature Biotechnology this week. The discovery of this target ― a viral protein called nucleoprotein and of a drug that can inhibit it may lead to the development of therapies for influenza infection.
Because new strains of influenza A virus continue to emerge, some of which may be resistant to current drugs, it is necessary to continue to develop new antiviral therapeutics and strategies. By screening a large library of small molecules, Richard Y Kao and colleagues found that a small molecule called nucleozin can suppress influenza A viral replication in both cell lines and mice. Nucleozin targets the viral protein nucleoprotein. Since the influenza A genome encodes only 11 proteins, the finding that nucleoprotein is druggable may represent a significant addition to the targets available to drug developers. The scientists believe that similar screens may uncover further targets.
doi: 10.1038/nbt.1638
Research highlights
-
Jul 1
Criminology: Predicting police enforcement bias in major US citiesNature Human Behaviour
-
Jul 1
Evolution: Pandas gave bamboo the thumbs up at least six million years agoScientific Reports
-
Jul 1
Space health: The path of most resistance could help limit bone loss during spaceflightScientific Reports
-
Jun 30
Genomics: Gray wolf genome hints at dual ancestry of dogsNature
-
Jun 30
Evolution: Hawks learn on the fly to swoop up before perchingNature
-
Jun 30
Microbiology: Transmission of gastrointestinal viruses in salivaNature